Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125788631 | 12578863 | 1 | I | 2010 | 20160711 | 20160721 | 20160721 | PER | US-PFIZER INC-2016342486 | PFIZER | 38.00 | YR | M | Y | 143.31000 | KG | 20160721 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125788631 | 12578863 | 1 | PS | GEODON | ZIPRASIDONE HYDROCHLORIDEIPRASIDONE MESYLATE | 1 | 200 MG, DAILY | 20825 | 200 | MG | CAPSULE, HARD | ||||||||
| 125788631 | 12578863 | 2 | SS | GEODON | ZIPRASIDONE HYDROCHLORIDEIPRASIDONE MESYLATE | 1 | 80 MG, 3X/DAY | 20825 | 80 | MG | CAPSULE, HARD | TID | |||||||
| 125788631 | 12578863 | 3 | C | LUVOX | FLUVOXAMINE MALEATE | 1 | 300 MG, DAILY | 0 | 300 | MG | |||||||||
| 125788631 | 12578863 | 4 | C | WELLBUTRIN | BUPROPION HYDROCHLORIDE | 1 | 400 MG, DAILY | 0 | 400 | MG | |||||||||
| 125788631 | 12578863 | 5 | C | CLONAZEPAM. | CLONAZEPAM | 1 | 6 MG, DAILY | 0 | 6 | MG | |||||||||
| 125788631 | 12578863 | 6 | C | CLONAZEPAM. | CLONAZEPAM | 1 | 0 | ||||||||||||
| 125788631 | 12578863 | 7 | C | BUSPIRONE | BUSPIRONE HYDROCHLORIDE | 1 | 60 MG, DAILY | 0 | 60 | MG | |||||||||
| 125788631 | 12578863 | 8 | C | PRAZOSIN | PRAZOSIN | 1 | 1 MG, DAILY AT BED TIME | 0 | 1 | MG | |||||||||
| 125788631 | 12578863 | 9 | C | AMBIEN | ZOLPIDEM TARTRATE | 1 | 5 MG, AS NEEDED, AT BED | 0 | 5 | MG | |||||||||
| 125788631 | 12578863 | 10 | C | PREVACID | LANSOPRAZOLE | 1 | 30 MG, DAILY, BEFORE BREAKFAST | 0 | 30 | MG | |||||||||
| 125788631 | 12578863 | 11 | C | AMITIZA | LUBIPROSTONE | 1 | 24 UG, 2X/DAY | 0 | 24 | UG | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125788631 | 12578863 | 1 | Hallucination |
| 125788631 | 12578863 | 3 | Depression |
| 125788631 | 12578863 | 4 | Depression |
| 125788631 | 12578863 | 5 | Panic attack |
| 125788631 | 12578863 | 6 | Anxiety |
| 125788631 | 12578863 | 7 | Anxiety |
| 125788631 | 12578863 | 8 | Nightmare |
| 125788631 | 12578863 | 9 | Insomnia |
| 125788631 | 12578863 | 10 | Gastrooesophageal reflux disease |
| 125788631 | 12578863 | 11 | Irritable bowel syndrome |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125788631 | 12578863 | Drug effect incomplete | |
| 125788631 | 12578863 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125788631 | 12578863 | 1 | 200906 | 0 |